Cellectar Biosciences

NASDAQ: CLRB
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#37346
Country Rank
#4756
Market Cap
16.21 M
Price
0.298
Change (%)
2.16%
Volume
1.79 M

Cellectar Biosciences's latest marketcap:

16.21 M

As of 06/23/2025, Cellectar Biosciences's market capitalization has reached $16.21 M. According to our data, Cellectar Biosciences is the 37346th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 16.21 M
Revenue (ttm) 0
Net Income (ttm) -24,543,492
Shares Out 54.36 M
EPS (ttm) -0.78
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 06/23/2025

Cellectar Biosciences's yearly market capitalization.

Cellectar Biosciences has seen its market value drop from $44.6 M to $16.21 M since 2005, representing a total decrease of 63.67% and an annual compound decline rate (CAGR) of 5.06%.
Date Market Cap Change (%) Global Rank
06/23/2025 $16.21 M 36.59% 37346
12/31/2024 $12.3 M -63.82% 36964
12/29/2023 $34 M 112.5% 30377
12/30/2022 $16 M -60.59% 33805
12/31/2021 $40.6 M -27.24% 28811
12/31/2020 $55.8 M 164.45% 24075
12/31/2019 $21.1 M 185.14% 26179
12/31/2018 $7.4 M -65.9% 28761
12/29/2017 $21.7 M 233.85% 25224
12/30/2016 $6.5 M 3.17% 26332

Company Profile

Cellectar Biosciences was founded in 2002 in United States. on the Nasdaq Stock Market. With 11 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

  • What is Cellectar Biosciences's (CLRB) current market cap?
    As of 06/23/2025, Cellectar Biosciences (including the parent company, if applicable) has an estimated market capitalization of $16.21 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Cellectar Biosciences global market capitalization ranking is approximately 37346 as of 06/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.